The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-12 of 12 articles
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study
van der Sangen NM,
Claessen B,
Küçük IT,
den Hartog A,
Baan J,
Beijk M,
Delewi R,
van de Hoef TP,
Knaapen P,
Lemkes J,
Marques K,
Nap A,
Verouden NJ,
Vis MM,
de Winter R,
Kikkert WJ,
Appelman Y,
Henriques J
May 12, 2023 | 10.4244/EIJ-D-22-00886
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf RJ,
Arkenbout K,
Kraak R,
Weevers A,
Piek J,
de Winter R,
Tijssen J,
Henriques J,
Wykrzykowska JJ,
Ijsselmuiden A,
Kauer F,
Beijk M,
Vis MM,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial
Barbanti M,
van Mourik M,
Spence M,
Iacovelli F,
Martinelli G,
Muir D,
Saia F,
Bortone A,
Densem C,
van der Kley F,
Bramlage P,
Vis MM,
Tamburino C
June 20, 2019 | 10.4244/EIJ-D-18-01197
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI
Tijssen R,
Kraak R,
Hofma S,
van der Schaaf RJ,
Arkenbout EK,
Weevers A,
Elias J,
van Dongen I,
Koch K,
Baan Jr J,
Vis MM,
de Winter R,
Piek J,
Tijssen J,
Henriques J,
Wykrzykowska JJ
July 20, 2018 | 10.4244/EIJ-D-18-00335
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria
Kraak R,
Grundeken M.J,
Hassell M,
Elias J,
Koch K,
Henriques J,
Piek J,
Baan Jr J,
Vis MM,
Thijssen J,
de Winter R,
Wykrzykowska JJ
August 5, 2016 | 10.4244/EIJV12I5A95
Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry
Kraak R,
Hassell M,
Grundeken M.J,
Koch K,
Henriques J,
Piek J,
Baan Jr J,
Vis MM,
Arkenbout EK,
Thijssen J,
de Winter R,
Wykrzykowska JJ
February 20, 2015 | 10.4244/EIJY14M08_08
Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus
Hoebers L,
Claessen B,
Woudstra P,
De Vries J,
Wykrzykowska JJ,
Vis MM,
Baan Jr J,
Koch K,
Thijssen J,
de Winter R,
Piek J,
Henriques J
May 20, 2014 | 10.4244/EIJV10I1A15
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies
Grundeken M.J,
Asgedom S,
Damman P,
Lesiak M,
Norell M,
Garcia E,
Bethencourt A,
Woudstra P,
Koch K,
Vis MM,
Henriques J,
Onuma Y,
Foley DP,
Bartorelli A,
Stella P,
Thijssen J,
de Winter R,
Wykrzykowska JJ
June 28, 2013 | 10.4244/EIJV9I2A34
Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction
Engstrom A,
Sjauw K,
Baan Jr J,
Remmelink M,
Claessen B,
Kikkert WJ,
Hoebers L,
Vis MM,
Koch K,
Meuwissen M,
Thijssen J,
de Winter R,
Piek J,
Henriques J
February 21, 2011
The influence of gender on short- and long-term outcome after primary PCI and delivered medical care for ST-segment elevation myocardial infarction
Sjauw K,
Stegenga N,
Engstrom A,
van der Schaaf RJ,
Vis MM,
Macleod A,
Baan Jr J,
Koch K,
de Winter R,
Thijssen J,
Piek J,
Henriques J
February 25, 2010
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023